Molecular and trophic mechanisms of tumorigenesis

Andy Levy1

  • 1Henry Wellcome Labs for Integrative Neuroscience & Endocrinology, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY, UK. a.levy@bris.ac.uk

Insights

Most pituitary adenomas stabilize after initial growth, but their behavior is hard to predict. Current genetic causes like GNAS1 mutations explain only a small fraction of these tumors.

Area of Science:

  • Endocrinology
  • Oncology
  • Genetics

Background:

  • Pituitary adenomas, particularly macroadenomas and all microadenomas, often achieve stability post-deregulated growth.
  • Predicting pituitary adenoma behavior is challenging due to the rarity of classical oncogene/tumor suppressor mutations and lack of reliable markers.

Purpose of the Study:

  • To explore the underlying genetic and molecular mechanisms driving pituitary adenoma development and behavior.
  • To identify reliable predictors of pituitary adenoma growth and stability.

Main Methods:

  • Review of existing literature on pituitary adenoma genetics and behavior.
  • Analysis of known genetic mutations (GNAS1, MEN1, Carney complex, AHI1) and chromosomal abnormalities (11q13) in pituitary adenomas.

Main Results:

  • Classical proto-oncogene activation and tumor suppressor mutations are infrequent causes of pituitary adenomas.
  • Specific genetic alterations like GNAS1 activation, mutations in MEN1 and Carney complex-associated genes, AHI1 mutations, and 11q13 region abnormalities in familial cases account for a small subset of pituitary adenomas.

Conclusions:

  • The primary drivers of pituitary adenoma pathogenesis remain largely unknown, necessitating further research.
  • Current genetic findings do not sufficiently explain the behavior of most pituitary adenomas, indicating a need for future discoveries.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...